| Literature DB >> 26957230 |
Jing Sun1, Fangyan Wang2, Guangliang Hong3, Mengqi Pang4, Hailing Xu4, Haixiao Li4, Feng Tian4, Renchi Fang4, Ye Yao4, Jiaming Liu5.
Abstract
Sodium butyrate (NaB) has exhibited neuroprotective activity. This study aimed to explore that NaB exerts beneficial effects on chronic unpredictable mild stress (CUMS)-induced depression-like behaviors and its possible mechanisms. The behavioral tests including sucrose preference test (SPT), open field test (OFT), tail suspension test (TST) and forced swimming test (FST) were to evaluate the antidepressant effects of NaB. Then changes of Nissl's body in the hippocampus, brain serotonin (5-HT) concentration, brain-derived neurotrophic factor (BDNF) and tight junctions (TJs) proteins level were assessed to explore the antidepressant mechanisms. Our results showed that CUMS caused significant depression-like behaviors, neuropathological changes, and decreased brain 5-HT concentration, TJs protein levels and BDNF expression in the hippocampus. However, NaB treatment significantly ameliorated behavioral deficits of the CUMS-induced mice, increased 5-HT concentration, increased BDNF expression, and up-regulated Occludin and zonula occludens-1(ZO-1) protein levels in the hippocampus, which demonstrated that NaB could partially restore CUMS-induced blood-brain barrier (BBB) impairments. Besides, the pathologic changes were alleviated. In conclusion, these results demonstrated that NaB significantly improved depression-like behaviors in CUMS-induced mice and its antidepressant actions might be related with, at least in part, the increasing brain 5-HT concentration and BDNF expression and restoring BBB impairments.Entities:
Keywords: 5-HT; Antidepressant; BDNF; Blood–brain barrier (BBB); Chronic unpredictable mild stress (CUMS); Sodium butyrate
Mesh:
Substances:
Year: 2016 PMID: 26957230 DOI: 10.1016/j.neulet.2016.03.003
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046